Ethics & Conflicts Of Interest In Phase 1 Trials
This session addresses the ethical challenges and conflicts of interest that arise in oncology trials, with a focus on Phase I studies. Key topics include the influence of financial losses on trial integrity, the ethical dilemmas posed by study cancellations, and solutions such as risk-based payment models and early termination policies. Attendees will gain insights into upholding ethical standards while navigating the financial and operational complexities of oncology research.
Learning Objectives:
– Identify key ethical challenges and conflicts of interest in Phase I oncology trials.
– Evaluate the impact of financial losses on trial integrity and patient outcomes.
– Develop strategies to address ethical issues related to study cancellations.
